Expand AMRX Menu
AMRX MENU

AMRX Latest Press Releases

-- December 9, 2025 --

Amneal Receives U.S. FDA Approval for Epinephrine Injection in Single- and Multi-Dose Vials for U.S. Hospitals Globe Newswire 4:01 PM

-- December 5, 2025 --

Amneal Announces Positive Interim Phase 4 ELEVATE-PD Results With CREXONT for Parkinson's Disease Globe Newswire 8:00 AM

-- December 2, 2025 --

Amneal to Participate in Upcoming Investor Conferences Globe Newswire 8:00 AM
Amneal Receives U.S. FDA Approval for Albuterol Sulfate Inhalation Aerosol Globe Newswire 8:00 AM

-- December 1, 2025 --

Amneal Announces U.S. FDA Approval of Cyclosporine Ophthalmic Emulsion 0.05% Globe Newswire 4:01 PM

-- November 13, 2025 --

Amneal Receives U.S. FDA Approval for Iohexol Injection Globe Newswire 4:01 PM

-- October 30, 2025 --

Amneal Reports Third Quarter 2025 Financial Results Globe Newswire 6:00 AM

-- October 29, 2025 --

Amneal Receives U.S. FDA Tentative Approval for Beclomethasone Dipropionate HFA Inhalation Aerosol Globe Newswire 4:05 PM

-- October 27, 2025 --

Amneal Launches Brekiya - the First and Only DHE Autoinjector for Adults with Migraine With or Without Aura and Cluster Headaches Globe Newswire 8:00 AM

-- October 6, 2025 --

Kashiv Biosciences Announces Submission of Biologics License Application to U.S. FDA and Acceptance of Market Authorization Application by European Medicines Agency for ADL-018, a Proposed Biosimilar to XOLAIR (omalizumab) Business Wire 8:00 AM

-- September 30, 2025 --

Amneal to Report Third Quarter 2025 Results on October 30, 2025 Globe Newswire 4:05 PM

-- September 26, 2025 --

Amneal Announces BLA Submission of Biosimilar Candidate to XOLAIR (omalizumab) Globe Newswire 8:00 AM

-- September 23, 2025 --

Amneal Receives U.S. FDA Approval for Bimatoprost Ophthalmic Solution, 0.01% Globe Newswire 8:00 AM

-- September 11, 2025 --

Amneal Receives U.S. FDA Approval of Sodium Oxybate Oral Solution Globe Newswire 8:00 AM

-- September 4, 2025 --

Amneal Receives U.S. FDA Approval for Risperidone Extended-Release Injectable Suspension Globe Newswire 4:01 PM

-- August 5, 2025 --

Knight Therapeutics Announces Regulatory Submission of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Mexico Globe Newswire 7:30 AM
Amneal Reports Second Quarter 2025 Financial Results Globe Newswire 6:00 AM
Market Data Delayed 15 Minutes